Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO
Articolo
Data di Pubblicazione:
2011
Citazione:
Harter, P., Sehouli, J., Reuss, A., Hasenburg, A., Scambia, G., Cibula, D., Mahner, S., Vergote, I., Reinthaller, A., Burges, A., Hanker, L., Pölcher, M., Kurzeder, C., Canzler, U., Petry, K., Obermair, A., Petru, E., Schmalfeldt, B., Lorusso, D., Du Bois, A., Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO, <>, 2011; 21 (2): 289-295. [doi:10.1097/IGC.0b013e31820aaafd] [http://hdl.handle.net/10807/3708]
Abstract:
The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
Adult; Aged; Aged, 80 and over; Female; Health Status Indicators; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies
Elenco autori:
Harter, P; Sehouli, J; Reuss, A; Hasenburg, A; Scambia, Giovanni; Cibula, D; Mahner, S; Vergote, I; Reinthaller, A; Burges, A; Hanker, L; Pölcher, M; Kurzeder, C; Canzler, U; Petry, Ku; Obermair, A; Petru, E; Schmalfeldt, B; Lorusso, Domenica; Du Bois, A.
Link alla scheda completa:
Pubblicato in: